The key point: BPC-157 should only be considered with guidance from a licensed provider who understands peptide therapy, safety, and current regulations
The once-weekly injectable was originally used to help manage diabetes but gained FDA approval in 2021 for "chronic weight management." It suppresses appetite by balancing out the body's hunger hormones and delaying digestion, and has been shown to lead to a 15% to 20% loss of body weight over 68 weeks, Insider's Gabby Landsverk previously reported
Many people don't see significant results until they reach higher doses in months 2-3
Bal, T., Doan, S., zcan, O., abalak, M
The agency's position, restated in its public guidance, is that "retatrutide and cagrilintide cannot be used in compounding under federal law" because they are investigational compounds not eligible under sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act [6][14][15]
Brandt Pores No More Luminizer Primer 1/0oz $40.00 Total Price: $80.00 ADD BOTH TO CART